The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery.

[1]  Marlies Sachs,et al.  Thrombospondin Type 1 Domain-Containing 7A Localizes to the Slit Diaphragm and Stabilizes Membrane Dynamics of Fully Differentiated Podocytes. , 2019, Journal of the American Society of Nephrology : JASN.

[2]  Zhe Lv,et al.  Serum phospholipase A2 receptor antibodies and immunoglobulin G subtypes in adult idiopathic membranous nephropathy: Clinical value assessment. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[3]  David W. Johnson,et al.  Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. , 2019, Kidney international.

[4]  J. Lieske,et al.  Noninvasive diagnosis of primary membranous nephropathy using phospholipase A2 receptor antibodies. , 2019, Kidney international.

[5]  H. Debiec,et al.  Factor H Autoantibodies and Membranous Nephropathy. , 2018, The New England journal of medicine.

[6]  J. Anaya,et al.  Molecular mimicry and autoimmunity. , 2018, Journal of autoimmunity.

[7]  Hong Zhang,et al.  Primary glomerular nephropathy among hospitalized patients in a national database in China , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[8]  J. Rossjohn,et al.  HLA and kidney disease: from associations to mechanisms , 2018, Nature Reviews Nephrology.

[9]  J. Obata,et al.  Human soluble phospholipase A2 receptor is an inhibitor of the integrin-mediated cell migratory response to collagen-I. , 2018, American journal of physiology. Cell physiology.

[10]  Su-xia Wang,et al.  Clinical implications of pathological features of primary membranous nephropathy , 2018, BMC Nephrology.

[11]  J. Thurman,et al.  Alternative Pathway Is Essential for Glomerular Complement Activation and Proteinuria in a Mouse Model of Membranous Nephropathy , 2018, Front. Immunol..

[12]  P. Brenchley,et al.  Peptide GAM immunoadsorption therapy in primary membranous nephropathy (PRISM): Phase II trial investigating the safety and feasibility of peptide GAM immunoadsorption in anti‐PLA2R positive primary membranous nephropathy , 2018, Journal of clinical apheresis.

[13]  M. Matsushita,et al.  Glomerular mannose-binding lectin deposition in intrinsic antigen-related membranous nephropathy , 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  J. Wetzels,et al.  Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab. , 2018, Kidney international.

[15]  I. Koneczny.  A New Classification System for IgG4 Autoantibodies , 2018, Front. Immunol..

[16]  K. Dahan,et al.  Phospholipase A2 Receptor 1 Epitope Spreading at Baseline Predicts Reduced Likelihood of Remission of Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[17]  C. Meyer-Schwesinger,et al.  A Heterologous Model of Thrombospondin Type 1 Domain-Containing 7A-Associated Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[18]  J. Coller,et al.  Codon optimality, bias and usage in translation and mRNA decay , 2017, Nature Reviews Molecular Cell Biology.

[19]  U. Beuers,et al.  On the role of IgG4 in inflammatory conditions: lessons for IgG4-related disease. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[20]  Michael J. Randles,et al.  PLA2R binds to the annexin A2-S100A10 complex in human podocytes , 2017, Scientific Reports.

[21]  K. Dahan,et al.  B- and T-cell subpopulations in patients with severe idiopathic membranous nephropathy may predict an early response to rituximab. , 2017, Kidney international.

[22]  F. Wang,et al.  MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[23]  Zhi-Hong Liu,et al.  HLA-DRB1*15:01 and HLA-DRB3*02:02 in PLA2R-Related Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[24]  Ming-hui Zhao,et al.  Plasma from patients with anti-glomerular basement membrane disease could recognize microbial peptides , 2017, PloS one.

[25]  A. Payne,et al.  Setting the target for pemphigus vulgaris therapy. , 2017, JCI insight.

[26]  E. Ollier,et al.  Anti-phospholipase A2 receptor antibody levels at diagnosis predicts spontaneous remission of idiopathic membranous nephropathy , 2017, Clinical kidney journal.

[27]  D. Salant,et al.  An Indirect Immunofluorescence Method Facilitates Detection of Thrombospondin Type 1 Domain-Containing 7A-Specific Antibodies in Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[28]  K. Nath,et al.  A Proposal for a Serology-Based Approach to Membranous Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.

[29]  J. Valenzuela,et al.  Non-infectious environmental antigens as a trigger for the initiation of an autoimmune skin disease. , 2016, Autoimmunity reviews.

[30]  V. Jha,et al.  PLA2R antibodies, glomerular PLA2R deposits and variations in PLA2R1 and HLA-DQA1 genes in primary membranous nephropathy in South Asians. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[31]  K. Budde,et al.  Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. , 2016, The Journal of clinical investigation.

[32]  J. Schwartz,et al.  Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China. , 2016, Journal of the American Society of Nephrology : JASN.

[33]  Y. Wada,et al.  Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy , 2016, PloS one.

[34]  S. Baldovino,et al.  New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature. , 2016, Autoimmunity reviews.

[35]  J. Rendu,et al.  Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency. , 2016, Journal of the American Society of Nephrology : JASN.

[36]  G. Lambeau,et al.  Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy. , 2016, Journal of the American Society of Nephrology : JASN.

[37]  Lukas Ma,et al.  IgG4 anti-phospholipase A2 receptor might activate lectin and alternative complement pathway meanwhile in idiopathic membranous nephropathy: an inspiration from a cross-sectional study , 2016, Immunologic Research.

[38]  V. Jha,et al.  Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. , 2015, Kidney international.

[39]  G. Lambeau,et al.  Cross-reactivity of anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy. , 2015, Biochimie.

[40]  J. Wetzels,et al.  Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up. , 2015, Kidney international.

[41]  H. Debiec,et al.  Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy. , 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[42]  G. Remuzzi,et al.  Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[43]  L. Beck.  The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π. , 2015, Journal of the American Society of Nephrology : JASN.

[44]  T. Jowitt,et al.  Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[45]  R. Glassock,et al.  Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy. , 2015, Journal of the American Society of Nephrology : JASN.

[46]  J. Klein,et al.  Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. , 2015, The New England journal of medicine.

[47]  U. Panzer,et al.  M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[48]  W. Liu,et al.  The Diagnosis Accuracy of PLA2R-AB in the Diagnosis of Idiopathic Membranous Nephropathy: A Meta-Analysis , 2014, PloS one.

[49]  J. Wetzels,et al.  Association of anti-PLA₂R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[50]  M. Ando,et al.  Smoking Is a Risk Factor for the Progression of Idiopathic Membranous Nephropathy , 2014, PloS one.

[51]  C. Ponticelli,et al.  Glomerular diseases: membranous nephropathy--a modern view. , 2014, Clinical journal of the American Society of Nephrology : CJASN.

[52]  J. Mölne,et al.  Circulating anti-glomerular basement membrane antibodies with predominance of subclass IgG4 and false-negative immunoassay test results in anti-glomerular basement membrane disease. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[53]  A. Collins,et al.  A Temporal Model of Human IgE and IgG Antibody Function , 2013, Front. Immunol..

[54]  P. Hou,et al.  Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.

[55]  J. Wetzels,et al.  Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[56]  E. Messias,et al.  Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies , 2013, Modern Pathology.

[57]  Ming-hui Zhao,et al.  The distribution of IgG subclass deposition on renal tissues from patients with anti-glomerular basement membrane disease , 2013, BMC Immunology.

[58]  J. Wetzels,et al.  Phospholipase A2 receptor (PLA2R1) sequence variants in idiopathic membranous nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.

[59]  B. Rovin,et al.  IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression , 2013, Modern Pathology.

[60]  U. Panzer,et al.  Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. , 2012, Kidney international.

[61]  J. Wetzels,et al.  Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. , 2012, Journal of the American Society of Nephrology : JASN.

[62]  Jai Radhakrishnan,et al.  Notice , 2012, Kidney International Supplements.

[63]  J. Wetzels,et al.  anti-Pla 2 r antibodies in membranous nephropathy: ready for routine clinical practice? , 2012 .

[64]  David M. Beck,et al.  Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. , 2011, Journal of the American Society of Nephrology : JASN.

[65]  L. Kiemeney,et al.  Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. , 2011, The New England journal of medicine.

[66]  H. Debiec,et al.  PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. , 2011, The New England journal of medicine.

[67]  克治 桑門.  海外論文紹介 : M-Type Phospholipase A2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy , 2010 .

[68]  F. Tsai,et al.  Association of phospholipase A2 receptor 1 polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan , 2010, Journal of Biomedical Science.

[69]  Eun Kyoung Lee,et al.  Single Nucleotide Polymorphisms in the Phospholipase A2 Receptor Gene Are Associated with Genetic Susceptibility to Idiopathic Membranous Nephropathy , 2010, Nephron Clinical Practice.

[70]  E. Neilson,et al.  Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. , 2010, The New England journal of medicine.

[71]  T. Fujita,et al.  IgG subclasses and complement pathway in segmental and global membranous nephropathy , 2010, Pediatric Nephrology.

[72]  David M. Beck,et al.  M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. , 2009, The New England journal of medicine.

[73]  Ming-hui Zhao,et al.  The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. , 2009, Human immunology.

[74]  Ming-hui Zhao,et al.  Natural anti-GBM antibodies from normal human sera recognize alpha3(IV)NC1 restrictively and recognize the same epitopes as anti-GBM antibodies from patients with anti-GBM disease. , 2007, Clinical immunology.

[75]  M. Triggiani,et al.  Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor1 , 2005, The Journal of Immunology.

[76]  J. Levy,et al.  Tolerance and autoimmunity in anti-GBM disease. , 2003, Journal of the American Society of Nephrology : JASN.

[77]  D. Hémon,et al.  Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. , 2000, Kidney international.

[78]  B. Hudson,et al.  The Goodpasture Autoantigen , 2000, The Journal of Biological Chemistry.

[79]  H. Burkhardt,et al.  Goodpasture Disease , 1999, The Journal of Biological Chemistry.

[80]  J. Wetzels,et al.  In Vivo Antibody-mediated Modulation of Aminopeptidase A in Mouse Proximal Tubular Epithelial Cells , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[81]  R. Würzner,et al.  Glomerular deposition of mannose-binding lectin in human glomerulonephritis. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[82]  M. Lazdunski,et al.  Identification of the Binding Domain for Secretory Phospholipases A2 on Their M-type 180-kDa Membrane Receptor * , 1995, The Journal of Biological Chemistry.

[83]  G. Mohácsi,et al.  [Secondary membranous glomerulonephritis]. , 1991, Orvosi hetilap.

[84]  R. Vaughan,et al.  A DQA1 allele is strongly associated with idiopathic membranous nephropathy. , 1989, Tissue antigens.

[85]  E. J. Acheson,et al.  STRONG ASSOCIATION BETWEEN IDIOPATHIC MEMBRANOUS NEPHROPATHY AND HLA-DRW3. , 1979, The Lancet.

[86]  K. Dahan,et al.  Retreatment with rituximab for membranous nephropathy with persistently elevated titers of anti-phospholipase A2 receptor antibody. , 2019, Kidney international.

[87]  K. Dahan,et al.  Rituximab for Severe Membranous Nephropathy: A 6-Month Trial with Extended Follow-Up. , 2017, Journal of the American Society of Nephrology : JASN.

[88]  F. Kronenberg,et al.  Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies. , 2017, Nephrology, Dialysis and Transplantation.

[89]  B. Kasiske,et al.  KDIGO Clinical Practice Guideline for Glomerulonephritis , 2012 .

[90]  S. Ritz.  Air pollution as a potential contributor to the 'epidemic' of autoimmune disease. , 2010, Medical hypotheses.